Posts by admin

Transposons

                               INTRODUCTION TO TRANSPOSONS

                                                (Jumping Genes)

 Author: Waseem Ashfaq

            Transposons are pieces of DNA that can “jump” into novel positions in the genome. There are numerous different types of transposon which differ from each other in many ways. They have been exploited very extensively in molecular biology research. They can insert themselves into DNA without requiring any similar sequence to be present in themselves and their “target”. This makes them powerful mutagens, since their insertion into a gene will generally prevent the gene from producing a functional protein. As mutagens, their effect is not always completely random, as some do have preferences for certain sequences or types of chromatin, and others will transpose preferentially to adjacent regions rather than randomly throughout the genome. Generally, a minimum of two things are required for transposition.

             The first is a gene which encodes transposase enzyme and which can recognize the ends of the transposon, excise the transposon (or a copy of it) from its starting point, cut DNA randomly or semi-randomly elsewhere, and catalyze the movement of the transposon from its starting point to its new target. The transposase can be encoded either by the transposon itself (in which case the transposon is often referred to as being “autonomous”) or elsewhere – on another transposon, for example, or on a plasmid. Transposons which rely on a transposase which they do not themselves carry are called “non-autonomous”. They occur naturally, and any autonomous transposon can be converted to a non-autonomous one by removing the transposase gene from it. The second requirement for transposition are the sequences at the ends of the transposon, which are recognized by the transposase. This minimal requirement for an autonomous transposon is shown below. There are many variants on this theme! Transposons use many different mechanisms to jump around the genome, but they all boil down to two basic types: replicative and nonreplicative. Replicative transposons copy themselves when they transpose, and leave one copy at the original site while inserting the second copy elsewhere. Non-replicative transposons are excised from their starting position and inserted elsewhere in the genome.

             In replicative transposition a), the transposon makes a copy of itself which is inserted randomly in the target DNA. In non-replicative transposition b), the transposon excises from its original position (usually leaving a small change in the sequence at the excision point) and reinserts at random in the target DNA.

They may be:

·        cause mutations

·        Increase (or decrease) the amount of DNA in the genome.

            These mobile segments of DNA are sometimes called “jumping genes”. They were discovered by Barbara McClintock early in her career, for which she was awarded a Nobel prize in 1983. The chromosomal basis of heredity was already well established by the time McClintock began her graduate training in the Botany Department at Cornell University. Her experiments laid the groundwork for a serie of cytogenetic discoveries by the Cornell maize genetics group between 1929 and 1935. McClintock developed a method for using broken chromosomes to generate new mutations. Among the progeny of plants that had received a broken chromosome from each parent, she observed unstable mutations at an unexpectedly high frequency, as well as a unique mutation that defined a regular site of chromosome breakage. These observations so intrigued her that she began an intensive investigation of the chromosome-breaking locus. Within several years she had learned enough to reach the conclusion, published in 1948, that the chromosome-breaking locus did something unknown for any genetic locus: it moved from one chromosomal location to another, a phenomenon she called transposition.

              Transposons are discrete segments of DNA capable of moving through the genome of their host via an RNA intermediate in the case of class I retrotransposon or via a “cut-and-paste” mechanism for class II DNA transposons. Since transposons take advantage of their host’s cellular machinery to proliferate in the genome and enter new hosts, transposable elements can be viewed as parasitic or “selfish DNA”. However, transposons may have been beneficial for their hosts as genome evolution drivers, thus providing an example of molecular mutualism. Some transposable elements contain heat-shock like promoters and their rate of transposition increases if the cell is subjected to stress, thus increasing the mutation rate under these conditions, which might be beneficial to the cell.

           The evolution of transposons and their effect on genome evolution is currently a dynamic field of study. Transposons are found in all major branches of life. The study of transposable genetic elements and transposition became the central theme of her genetic experiments from the mid 1940s until the end of her active research career. This was incredulous at the time, DNA was believed to be stable and invariable. They may or may not have originated in the last universal common ancestor, or arisen independently multiple times, or perhaps arisen once and then spread to other kingdoms by horizontal gene transfer. While transposons may confer some benefits on their hosts, they are generally considered to be selfish DNA parasites that live within the genome of cellular organisms. In this way, they are similar to viruses. Viruses and transposons also share features in their genome structure and biochemical abilities, leading to speculation that they share a common ancestor.

          Since excessive transposon activity can destroy a genome, many organisms seem to have developed mechanisms to reduce transposition to a manageable level. Bacteria may undergo high rates of gene deletion as part of a mechanism to remove transposons and viruses from their genomes while eukaryotic organisms may have developed the RNA interference (RNAi) mechanism as a way of reducing transposon activity. In the nematode Caenorhabditis elegans, some genes required for RNAi also reduce transposon activity.

          Interspersed Repeats within genomes are created by transposition events accumulating over evolutionary time. These Interspersed Repeats block gene conversion thereby catalyzing the formation of new genes. Transposons are therefore an evolutionary device promoting creation of new genes and protecting novel gene sequences from being overwritten by similar gene sequences through gene conversion.

There are three distinct types:

·  Class II Transposons consisting only of DNA that moves directly from place to place.

·   Class III Transposons; also known as Miniature Inverted-repeats Transposable Elements or MITEs.

·   Retrotransposons (Class I) that

           -first transcribe the DNA into RNA and then

          -use reverse transcriptase to make a DNA copy of the RNA to insert in a new location.

          Many transposons move by a “cut and paste” process: the transposon is cut out of its location (like command/control-X on your computer) and inserted into a new location (command/control-V). This process requires an enzyme — a transposase — that is encoded within some of these transposons. Transposase binds to:

·  both ends of the transposon, which consist of inverted repeats; that is, identical sequences reading in opposite directions.

·   a sequence of DNA that makes up the target site. Some transposases require a specific sequence as their target site; other can insert the transposon anywhere in the genome.

     After the transposon is ligated to the host DNA, the gaps are filled in by Watson-Crick base pairing. This creates identical direct repeats at each end of the transposon. Often transposons lose their gene for transposase; but as long as somewhere in the cell there is a transposon that can synthesize the enzyme, their inverted repeats are recognized and they, too, can be moved to a new location.

           Retrotransposons move by a “copy and paste” mechanism but in contrast to the transposons described above, the copy is made of RNA, not DNA.  The RNA copies are then transcribed back into DNA — using a reverse transcriptase — and these are inserted into new locations in the genome.  Many retrotransposons have long terminal repeats (LTRs) at their ends that may contain over 1000 base pairs in each. Like DNA transposons, retrotransposons generate direct repeats at their new sites of insertion. In fact, it is the presence of these direct repeats that often is the clue that the intervening stretch of DNA arrived there by retrotransposition. 42% of the entire human genome consists of retrotransposons.

            Retroviruses were first identified 80 years ago as agents involved in the onset of  cancer. More recently the AIDS epidemic has been shown to be due to the HIV retrovirus. In the early 1970s it was discovered that retroviruses had the ability to replicate their RNA genomes via conversion into DNA which became stably integrated in the DNA of the host cell. It is only comparatively recently that retroviruses have been recognized as particularly specialized forms of eukaryotic transposons. In effect they are transposons which move via RNA intermediates that usually can leave the host cells and infect other cells. The integrated DNA form (provirus) of the retrovirus bears a marked similarity to a transposon.

           The transposition cycle of retroviruses has other similarities to prokaryotic transposons, which suggest a distant familial relationship between these two types of transposon. Crucial intermediates in retrovirus transposition are extrachromosomal DNA molecules. These are generated by copying the RNA of the virus particle into DNA by a retrovirus-encoded polymerase called reverse transcriptase. The extra chromosomal linear DNA is the direct precursor of the integrated element and the insertion mechanism bears a strong similarity to “cut and paste” transposition.

            One family of transposons in the fruit fly Drosophila melanogaster are called P elements. They seem to have first appeared in the species only in the middle of the twentieth century. Within 50 years, they have spread through every population of the species. Transposons are also a widely used tool for mutagenesis of most experimentally tractable organisms.

             In bacteria, transposons can jump from chromosomal DNA to plasmid DNA and back, allowing for the transfer and permanent addition of genes such as those encoding antibiotic resistance (multi-antibiotic resistant bacterial strains can be generated in this way). Bacterial transposons of this type belong to the Tn family. When the transposable elements lack additional genes, they are known as insertion sequences. The most common form of transposon in humans is the Alu sequence. The Alu sequence is approximately 300 bases long and can be found between 300,000 and a million times in the human genome.

            Mariner-like elements are another prominent class of transposons found in multiple species including humans. The mariner transposon was first discovered by Jacobson and Hartl in drosophila1. This type-II trasposable element is known for its uncanny ability to be transmitted horizontally in many species. There are an estimated 14 thousand copies of mariner in the human genome composing of 2.6 million base pairs. These characteristics of the mariner transposon have inspired the science fiction novel titled, “The Mariner Project.”

 References:

 1.    McClintock, B. (June 1950). “The origin and behavior of mutable loci in maize”. Proc Natl Acad Sci U S A. 36 (6): 344–55.

2.    Rubin GM, Spradling AC (October 1982). “Genetic transformation of Drosophila with transposable element vectors”. Science 218 (4570): 348–53.

3.    Wilson MH, Coates CJ, George AL (January 2007). “PiggyBac transposon-mediated gene transfer in human cells”. Mol. Ther. 15 (1): 139–45.

4.    Mandal, P.K. & Kazazian, H.H., Jr. SnapShot: Vertebrate transposons. Cell 135, 192-192 e1 (2008).

5.    Kidwell, M.G. (2005). “Transposable elements.”. in (ed. T.R. Gregory). The Evolution of the Genome. San Diego: Elsevier. pp. 165–221. ISBN 0-12-301463-8. 

6.    Craig NL, Craigie R, Gellert M, and Lambowitz AM (ed.) (2002). Mobile DNA II. Washington, DC: ASM Press. ISBN 978-1555812096. 

7.    Lewin B (2000). Genes VII. Oxford University Press.. ISBN 978-0198792765. 

 

Contact :      waseemishfaq@gmail.com

 

 

Waseem ashfaq
Post Graduate Scholar,
University of Agriculture, Faisalabad.

Want to Live an Extra 10 Years?
Life Extension Membership
Read More

RNA Interference

RNA interference (RNAi) or double-stranded RNA (dsRNA) is a system within living cells that helps to control which genes are active and how active they are. siRNAs were first discovered by David Baulcombe’s group in Norwich, England, as part of post-transcriptional gene silencing (PTGS) in plants1 and later independently identified in wide variety of eukaryotic organisms. These dsRNAs are rapidly processed into short RNA duplexes of 21 to 28 nucleotides in length, which then guide the recognition and ultimately the cleavage of complementary single-stranded RNAs, such as messenger RNAs or viral genomic/antigenomic RNA (Fig. 1). According to their origin or function, naturally occurring small RNA have been described: short interfering RNAs (siRNA), repeat-associated short interfering RNA (rasiRNA or shRNA) and microRNA (miRNA). RNA interference has many biological functions – it is a vital part of the immune response against viruses and also downregulates gene expression by transcriptional silencing of genes or upregulates promoting by RNA activation. Finally, artificial introduction of long dsRNA or siRNA has been adopted as a tool to inactivate gene expression, both in cultured cells and in living organisms.http://www.biosyn.com/TEWdetail.aspx?TEWid=180

A biochemical understanding of the RNAi pathway was crucial to realizing that dsRNAs shorter than 30 base pairs (bp) could be used to trigger an RNAi response in mammals. Tuschl and colleagues showed that transfection of mammalian cells with short RNAs could induce the sequence-specific RNAi pathway, and so overcame the barrier to the use of RNAi as a genetic tool in mammals2. The impetus to use siRNAs and other small RNAs in mammalian cells also came from the long-standing view that protein kinase receptor (PKR) activation3 and similar responses were not effectively triggered by short dsRNAs. Following the initial reports, it took a remarkably short period of time for siRNAs triggers to be adopted as a standard component of the molecular biology toolkit. siRNAs can be introduced into mammalian cells using a variety of standard transfection methods. The strength and duration of the silencing response is determined by several factors: on a population basis, the silencing response is affected mainly by the overall efficiency of transfection, which can be addressed by optimizing conditions. In each cell, silencing depends on the amount of siRNA that is delivered and on the potential of each siRNA to suppress its target, or its potency. Even a relatively impotent siRNA can silence its target provided that sufficient quantities of the siRNA are delivered. However, essentially ‘forcing’ the system by delivering large amounts of reagent is likely to lead to numerous undesired effects.

Bio-Synthesis Inc. a leading provider for Custom Antibody, Custom Peptide Synthesis, Custom siRNA Synthesis, Organic Laboratory Technique, Antibiotic Peptides.

Want to Live an Extra 10 Years?
Life Extension Membership
Read More

Biotechnology -rna Genes

messenger RNA (mRNA) is generated in order to be translated into protein, numerous classes of “noncoding” RNAs also exist; these complex molecules all share the property of being nontranslatable. The classic categories of noncoding RNAs include ribosomal RNA and transfer RNA, both of which are involved in the translation process.

ver the past decade RNA interference (RNAi) has emerged as a natural mechanism for silencing gene expression. This ancient cellular antiviral response can be exploited to allow specific inhibition of the function of any chosen target gene. RNAi is proving to be an invaluable research tool, allowing much more rapid characterization of the function of known genes. More importantly, RNAi technology considerably bolsters functional genomics to aid in the identification of novel genes involved in disease processes. This review briefly describes the molecular principles underlying the biology of RNAi phenomenon and discusses the main technical issues regarding optimization of RNAi experimental design.

RNAi is a mechanism in molecular biology where the presence of certain fragments of double-stranded RNA (dsRNA) interferes with the expression of a particular gene which shares a similar sequence with the dsRNA.

This study defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence market size and growth for RNAi testing. The main objectives of this study are to:

1) understand the different sectors of RNAi testing market and to look at a description of the instruments, reagents and supplies marketed by major companies in each segment;

2) obtain a complete understanding of the individual RNAi-testing platforms-from basic principles to clinical applications;

3) discover feasible market opportunities by identifying high-growth applications in different analytical diagnostic areas, with a focus on the biggest and expanding markets;

4) focus on global industry developments and trends through an in-depth analysis of the major world markets for RNAi measurement technology, including growth forecasts; and

5) present market figures related to the current value of RNAi testing, market projections, market share, key players and sector growth rates.

Read more: biotechnology-online.blogspot.com

/>

Reference: findarticles, Market Wire

, Internal Medicine News

Read More

Rna Interference: Imgenex Launched the Psuppressoradeno Construction Kit for Adenovirus Mediated Gene Knockdown

RNA interference (RNAi) is the process of mRNA degradation that is induced by double-stranded RNA in a sequence-specific manner. RNAi has been observed in all eukaryotes, from yeast to mammals. The RNAi pathway is thought to be an ancient mechanism for protecting the host and its genome against viruses and rogue genetic elements that use double-stranded RNA (dsRNA) in their life cycles. They have also been shown to play a role not only in mRNA and dsRNA stability/degradation, but also in regulation of translation, transcription, chromatin structure, and genome integrity. In plants and animals, RNA silencing has been adapted to play a critical role in regulation of cell growth and differentiation using a class of small RNAs. In the RNA interference process, the dsRNAs get processed into 20-25 nucleotide (nt) small RNAs by an RNase III-like enzyme called Dicer. Then, the small RNAs assemble into endoribonuclease-containing complexes known as RNA-induced silencing complexes (RISCs), unwinding in the process. The small RNA strands subsequently guide the RISCs to complementary RNA molecules, where they cleave and destroy the cognate RNA (effecter step). Cleavage of cognate RNA takes place near the middle of the region bound by the siRNA strand. The small RNAs that provide target specificity to the silencing machinery includes short interfering RNAs (siRNAs), repeat-associated siRNAs (rasiRNAs), and microRNAs (miRNAs) and is distinguished by their origin. siRNAs are processed from dsRNA precursors made up of two distinct strands of perfectly base-paired RNA, while miRNAs originate from a single, long transcript that forms imperfectly base-paired hairpin structures. siRNAs were originally identified as intermediates in the RNAi pathway after induction by exogenous dsRNA; however, endogenous sources of siRNAs have now been recognized. The endogenous siRNAs are derived from repetitive sequences within the genome, and are termed repeat-associated siRNAs, or rasiRNAs. miRNAs were discovered through their critical roles in development and cellular regulation, and represent a large class of evolutionarily conserved RNAs. miRNAs have always been recognized as being of endogenous origin. RNA interference has emerged as a natural mechanism for silencing gene expression over the past decade. This ancient cellular antiviral response can be harnessed to allow specific inhibition of the function of any chosen target genes, including those involved in causing diseases such as cancer, AIDS, and hepatitis. It is already proving to be an invaluable research tool, allowing much more rapid characterization of the function of known genes. More importantly, the technology considerably bolsters functional genomics to aid in the identification of novel genes involved in disease processes. Last but not the least the technology can be harnessed as a novel therapeutic agent and is suitable for combating viral diseases, cancers and inflammatory diseases.

Imgenex (San Diego) recently launched the pSuppressorAdeno construction kit for adenovirus mediated gene knockdown. The kit provides the ability to infect a broad range of cell types, including many primary cell lines as well as dividing and nondividing cells, according to a company official. The kit also offers the flexibility to validate sequences using the nonviral expression plasmid prior to construction of adenoviruses, notes Sujay K. Singh, Ph.D., president and CEO of Imgenex, which markets plasmid-based RNA interference (RNAi) products. “One of the greatest advantages is the ability of recombinant adenovirus vectors to reduce gene expression both in vitro and in vivo,” he adds. RNAi, initially considered a bizarre attribute of petunias and later a gene-silencing mechanism in worms, is creating a stir as one of the hottest new technologies in molecular biology. It is revolutionizing the field of functional genomics.

For more information about“RNA interference” please visit www.imgenex.com/rna_interference.php />

Want to Live an Extra 10 Years?
Life Extension Membership
Read More

RNA Interference – A Regulatory Mechanism in a Living Cell

RNA Interference – A Regulatory Mechanism in a Living Cell

Imagine a situation where your cell fails to control the amount of protein being produced or the type of protein being produced. This may lead to a deadly disease.  But nature has equipped your body with regulatory mechanisms to check this as and when required. One such regulatory mechanism is RNA interference (RNAi), also known as post transcriptional gene silencing and quelling.

Andrew Fire and Craig Mello published their break-through study on the mechanism of RNA interference in Nature in 1998 [1].

 1          Why do you need something like RNAi mechanism?

DNA and RNA, are biopolymers and the sequence of their monomer subunits carries information for the proper cell functioning. The information, for the production of the required proteins is coded in DNA which gets transcribed to RNA and is ultimately translated into proteins. To make a living cell function properly, a cell needs to control both the type of the gene and the quantity of the gene to be activated at a particular time. RNA interference (RNAi) is a part of this control mechanism which is an outcome of post transcriptional gene silencing and acts at the level of RNA.

The molecules contributing to RNA interference are:

microRNA (miRNA) – small RNA molecules siRNA – small interfering RNA  2          Mechanism of RNA interference in a cell

 There are basically two dsRNA (double stranded RNA) pathways, exogenous and endogenous, which finally converge at the RISC complex.

2.1        Exogenous pathway

 During an exogenous pathway, dsRNA (coming from infection by a virus with an RNA genome or laboratory manipulations), gets directly imported into the cytoplasm. The imported dsRNA, activates a member of the RNase III family of dsRNA-specific ribonucleases protein, Dicer, within the cytoplasm. The Dicer further cleaves dsRNAs, to small 20-25 base-paired double-stranded fragments with a few unpaired 2-nucleotide 3′ overhangs on each end [2].  These Dicer-induced small double-stranded fragments are called “small interfering RNAs” (siRNAs).  Further, siRNAs get separated into single strands followed by integration into an active RNA-induced silencing complex (RISC). The siRNAs integrated into the RISC complex, base-pair to their target mRNA and induce cleavage of the mRNA.  This prevents the target mRNA from being translated.

 2.2        Endogenous pathway

During an endogenous pathway of RNA interference, in which pre-miRNAs play an active role, dsRNA originates within the cell.  Primary transcripts known as pre-microRNA (pre-miRNA) are produced by a set of RNA coding genes in the genome. These pre-miRNAs get processed to 70-nucleotide stem loop structures by the microprocessor complex, within the nucleus, further getting exported to the cytoplasm to be cleaved by Dicer. The pre-miRNAs undergo extensive post-transcriptional modification, to generate mature miRNAs, structurally similar to siRNAs produced from exogenous dsRNA.

 2.3        What differentiates the working mechanism of siRNAs from miRNAs?

The difference in the working mechanism of siRNAs and miRNAs lies in their specificity. The miRNAs, especially those in animals, show a lesser specific RNA interference. They show an incomplete base pairing to a target and inhibit the translation of many different mRNAs with similar sequences. In contrast, siRNAs are very specific in base-pairing and induce mRNA cleavage only at a single and specific target.

 2.4        Role of RISC complex

 The RNA-induced silencing complex (RISC) is made up of endonucleases called argonaute proteins. These proteins, are localized to specific regions in the cytoplasm called P-bodies (or cytoplasmic bodies or GW bodies), which are regions with high rates of mRNA decay. A separation of the two strands of siRNA is performed by the protein components of RISC complex. One of the two strands of siRNA known as the “guide strand”, binds the argonaute protein, thereby facilitating these proteins to cleave the target mRNA strand complementary to the bound siRNA.  The other strand of siRNA known as anti-guide strand or passenger strand is degraded during RISC activation.

2.5        Interference mechanism in eukaryotes and prokaryotes

The RNAi mechanism is found in many eukaryotes including animals. The regulatory RNAs, in case of prokaryotes are not analogous to miRNAs, as the dicer enzyme is not involved. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) systems, providing acquired immunity in prokaryotes, have been found to be analogus to the RNAi mechanism in eukaryotes. DNA of many bacteria and archaea are found to consist of direct repeats ranging in size from 24 to 48 base pairs known as CRISPR. The repeats show some dyad symmetry and are separated by spacers of similar length. Spacer sequences generally have a unique genome and some spacer sequences usually match the sequences in phage genomes. It has been recently demonstrated that, these spacers protect the cell from infection.

  3           Importance of RNAi mechanism 3.1        Defense mechanism in plants

Plants show an adaptive immune response against viruses and other foreign genetic material through this mechanism. Plants such as Arabidopsis thaliana, express multiple dicer homologs which specifically act against different viruses. In some cases, plant genomes also express endogenous siRNAs in response to bacterial infection.

Among animals, Drosophila, shows antiviral innate immunity against pathogens such as Drosophila X virus, through RNAi mechanism.    

 3.2        Regulation of genes  3.2.1       Downregulation

Endogenously expressed miRNAs play a significant role in:

Translational repression. Regulation of development – more specifically timing of morphogenesis. Maintenance of incompletely differentiated cell types such as stem cells

In plants, mainly genes of transcription factors are regulated by miRNAs.

 3.2.2       Upregulation

RNA sequences (siRNA and miRNA) that are complementary to parts of a promoter are dubbed which in turn increase gene transcription.

 3.2.3       Maintenance of genome stability

In the case of C. elegans and plants, RNAi mechanism blocks the action of transposons (mobile elements in the genome) and maintains the genome stability.

 3.3        Technological applications 3.3.1       Facilitating Gene-knockdown

To study the physiological effect, of a target gene in vivo a double stranded RNA, complementary to the target gene is introduced into the cell or organism. This is recognized as exogenous genetic material and activates the RNAi pathway, resulting into drastic decrease in the expression of a targeted gene. This technique is different from knock out technique, wherein the expression of gene is entirely eliminated.

 3.3.2       Application in functional genomics

Many plant genomes, have more than two homologous sets of chromosomes (polyploid) and tracing the location of a particular gene and its related function is challenging with the traditional genetic engineering methods. This problem is solved by the RNAi mechanism.

 3.3.3       Medical application

The introduction of siRNAs, has been found to be very useful in the treatment of diseases like macular degeneration and respiratory syncytial virus in case of mammals.  RNAi mechanism is also used as an antiviral therapy against diseases caused by herpes simplex virus type 2, hepatitis A, hepatitis B. RNAi-mechanism governs gene regulation in transgenic organisms, suggesting its role in gene therapy.

 3.3.4       Biotechnological application

To reduce the levels of natural toxins in food plants you can use a stable, heritable and specific siRNA against the toxin. For example:

Cotton seeds are rich in dietary proteins but unpalatable by humans as they contain a natural toxic terpenoid product, called gossypol. RNAi mechanism has been used to reduce the levels of delta-cadinene synthase, an enzyme essential for the production of gossypol. Cassava plants produce cyanogenic natural product, linamarin, and RNAi mechanism has been used to reduce its levels. 4          Conclusion

 RNAi machinery is like a weapon for the cells and helps them in defending against parasitic genes like viruses and transposons. It regulates development of an organism and proper function of its cells and tissues, as well as gene expression within the organism. RNAi is the latest experimental approach, used to detect the function and location of the gene. It also leads us to new applications in medicine.

 5         References

[1] Fire A, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 1998 Feb 19;391 (6669):806-11.

[2] Vermeulen A, Reynolds A. The contributions of dsRNA structure to Dicer specificity and efficiency. RNA. 2005 May;11(5):674-82.

Post Graduate in Bio-Chemistry and PG Diploma in Bio-informatics. Worked as a Bio-informatics professional for about 2 years and moved on to a home-based job since.
Webpage – purnasrinivas.webs.com

Want to Live an Extra 10 Years?
Life Extension Membership
Read More
Page 2 of 912345...Last »